BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 720478)

  • 1. Interaction of vinblastine analogues with tubulin.
    Zavala F; Guénard D; Potier P
    Experientia; 1978 Nov; 34(11):1479-9. PubMed ID: 720478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent results in the field of vinblastine group antitumour alkaloids. Biochemical studies].
    Potier P; Guénard D; Zavala F
    C R Seances Soc Biol Fil; 1979; 173(2):414-24. PubMed ID: 159763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class.
    Owellen RJ; Hartke CA; Dickerson RM; Hains FO
    Cancer Res; 1976 Apr; 36(4):1499-502. PubMed ID: 1260766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S; Vulevic B; Correia JJ
    Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energetics of vinca alkaloid interactions with tubulin.
    Lobert S; Correia JJ
    Methods Enzymol; 2000; 323():77-103. PubMed ID: 10944748
    [No Abstract]   [Full Text] [Related]  

  • 6. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
    Lobert S; Frankfurter A; Correia JJ
    Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
    Sertel S; Fu Y; Zu Y; Rebacz B; Konkimalla B; Plinkert PK; Krämer A; Gertsch J; Efferth T
    Biochem Pharmacol; 2011 Mar; 81(6):723-35. PubMed ID: 21219884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain.
    Bai R; Pettit GR; Hamel E
    Biochem Pharmacol; 1990 Jun; 39(12):1941-9. PubMed ID: 2353935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of tissue concentrations of vinca alkaloids by radioimmunoassay.
    Owellen RJ; Blair M; Van Tosh A; Hains FC
    Cancer Treat Rep; 1981; 65(5-6):469-75. PubMed ID: 7237468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of interaction of vinca alkaloids with tubulin: catharanthine and vindoline.
    Prakash V; Timasheff SN
    Biochemistry; 1991 Jan; 30(3):873-80. PubMed ID: 1988072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules.
    Himes RH
    Pharmacol Ther; 1991; 51(2):257-67. PubMed ID: 1784631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain.
    Bai R; Taylor GF; Cichacz ZA; Herald CL; Kepler JA; Pettit GR; Hamel E
    Biochemistry; 1995 Aug; 34(30):9714-21. PubMed ID: 7626642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer.
    Zhang Y; Yang SH; Guo XL
    Biomed Pharmacother; 2017 Dec; 96():659-666. PubMed ID: 29035832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptophycin 1 binds to tubulin at a site distinct from the colchicine binding site and at a site that may overlap the vinca binding site.
    Mooberry SL; Taoka CR; Busquets L
    Cancer Lett; 1996 Oct; 107(1):53-7. PubMed ID: 8913266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthesis of Navelbine prototype of a new series of vinblastine derivatives.
    Potier P
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):2-4. PubMed ID: 2540531
    [No Abstract]   [Full Text] [Related]  

  • 16. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.
    Himes RH; Kersey RN; Heller-Bettinger I; Samson FE
    Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
    Iqbal Z; Ochs S
    J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of water stress and nitrogen nutrition on regulation of Catharanthus roseus alkaloids metabolism].
    Zhang N; Wen Q; Feng H; Cao R; Zhou X; Tagn J; Wu N
    Zhongguo Zhong Yao Za Zhi; 2012 May; 37(10):1346-52. PubMed ID: 22860440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catharanthine C16 substituent effects on the biomimetic coupling with vindoline: preparation and evaluation of a key series of vinblastine analogues.
    Tam A; Gotoh H; Robertson WM; Boger DL
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6408-10. PubMed ID: 20932748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate?
    Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ
    Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.